118 related articles for article (PubMed ID: 10212389)
41. Design and synthesis of tetraol derivatives of 1,12-dicarba-closo-dodecaborane as non-secosteroidal vitamin D analogs.
Fujii S; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H
Bioorg Med Chem Lett; 2014 Sep; 24(18):4515-4519. PubMed ID: 25149512
[TBL] [Abstract][Full Text] [Related]
42. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
Ma L; Hamdi J; Wong F; Hawthorne MF
Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
[TBL] [Abstract][Full Text] [Related]
43. C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
Alvarez S; Khanwalkar H; Alvarez R; Erb C; Martínez C; Rodríguez-Barrios F; Germain P; Gronemeyer H; de Lera AR
ChemMedChem; 2009 Oct; 4(10):1630-40. PubMed ID: 19670208
[TBL] [Abstract][Full Text] [Related]
44. Characterization of the differential coregulator binding signatures of the Retinoic Acid Receptor subtypes upon (ant)agonist action.
Miro Estruch I; Melchers D; Houtman R; de Haan LHJ; Groten JP; Louisse J; Rietjens IMCM
Biochim Biophys Acta Proteins Proteom; 2017 Sep; 1865(9):1195-1206. PubMed ID: 28642153
[TBL] [Abstract][Full Text] [Related]
45. Dicarba-closo-dodecaborane(12) derivatives of phosphonium salts: easy formation of nido-carborane phosphonium zwitterions.
Ioppolo JA; Clegg JK; Rendina LM
Dalton Trans; 2007 May; (20):1982-5. PubMed ID: 17502929
[TBL] [Abstract][Full Text] [Related]
46. The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha.
Kamei Y; Kawada T; Mizukami J; Sugimoto E
Life Sci; 1994; 55(16):PL307-12. PubMed ID: 7934625
[TBL] [Abstract][Full Text] [Related]
47. Retinoid X receptor-antagonistic diazepinylbenzoic acids.
Ebisawa M; Umemiya H; Ohta K; Fukasawa H; Kawachi E; Christoffel G; Gronemeyer H; Tsuji M; Hashimoto Y; Shudo K; Kagechika H
Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1778-86. PubMed ID: 10748721
[TBL] [Abstract][Full Text] [Related]
48. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoĭtova EV
Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
[TBL] [Abstract][Full Text] [Related]
49. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids.
Le Q; Dawson MI; Soprano DR; Soprano KJ
Oncogene; 2000 Mar; 19(11):1457-65. PubMed ID: 10723137
[TBL] [Abstract][Full Text] [Related]
50. Two distinct actions of retinoid-receptor ligands.
Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
[TBL] [Abstract][Full Text] [Related]
51. Syntheses and reductions of C-dimesitylboryl-1,2-dicarba-closo-dodecaboranes.
Kahlert J; Böhling L; Brockhinke A; Stammler HG; Neumann B; Rendina LM; Low PJ; Weber L; Fox MA
Dalton Trans; 2015 Jun; 44(21):9766-81. PubMed ID: 25939355
[TBL] [Abstract][Full Text] [Related]
52. Syntheses and evaluation of naphthalenyl- and chromenyl-pyrrolyl-benzoic acids as potent and selective retinoic acid receptor alpha agonists.
Hibi S; Tagami K; Kikuchi K; Yoshimura H; Tai K; Hida T; Tokuhara N; Yamauchi T; Nagai M
Bioorg Med Chem Lett; 2000 Apr; 10(7):623-5. PubMed ID: 10762039
[TBL] [Abstract][Full Text] [Related]
53. (2,2':6',2' '-Terpyridine)platinum(II) complexes containing (thioalkyl)dicarba-closo-dodecaborane(12) ligands.
Todd JA; Turner P; Ziolkowski EJ; Rendina LM
Inorg Chem; 2005 Sep; 44(18):6401-8. PubMed ID: 16124820
[TBL] [Abstract][Full Text] [Related]
54. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
[TBL] [Abstract][Full Text] [Related]
55. [Binding activity of retinoids with recombinant human retinoic acid receptor RAR alpha].
Cao X; Han R
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):193-5. PubMed ID: 10921005
[TBL] [Abstract][Full Text] [Related]
56. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
57. Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells.
Matsushima Y; Kawachi E; Tanaka H; Kagechika H; Hashimoto Y; Shudo K
Biochem Biophys Res Commun; 1992 Dec; 189(2):1136-42. PubMed ID: 1335240
[TBL] [Abstract][Full Text] [Related]
58. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells.
Mehta K; McQueen T; Neamati N; Collins S; Andreeff M
Cell Growth Differ; 1996 Feb; 7(2):179-86. PubMed ID: 8822201
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4).
Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI
Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427
[TBL] [Abstract][Full Text] [Related]
60.
Gruzdev DA; Telegina AA; Levit GL; Krasnov VP
J Org Chem; 2022 Apr; 87(8):5437-5441. PubMed ID: 35377641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
